Aptamer-Mediated Dual-Loaded Liposomal Nanosystem for Synergistic Therapy in Hepatocellular Carcinoma via mTOR/HIF-1α/VEGF Pathway
International Journal of Nanomedicine · 2026
DOI: 10.2147/ijn.s556912 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2026. Verfasst von Aiqiu Wei und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Hunan University of Chinese Medicine, Changsha, 410208, People's Republic of China. Hauptthemen laut MEDLINE: Liposomes, Liver Neoplasms, Carcinoma, Hepatocellular, Cantharidin. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Hunan University of Chinese Medicine, Changsha, 410208, People's Republic of China.
- Hunan Kelun Pharmaceutical Co., Ltd, Yueyang, 414024, People's Republic of China.
ORCID-Profile: Jincheng He, Xinhua Xia
Zitieren
APA
Wei, A., Zhong, Z., Zhang, Y., He, J., Pang, H., Xia, X., & Zhang, X. (2026). Aptamer-Mediated Dual-Loaded Liposomal Nanosystem for Synergistic Therapy in Hepatocellular Carcinoma via mTOR/HIF-1α/VEGF Pathway. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s556912
Vancouver
Wei A, Zhong Z, Zhang Y, He J, Pang H, Xia X, et al. Aptamer-Mediated Dual-Loaded Liposomal Nanosystem for Synergistic Therapy in Hepatocellular Carcinoma via mTOR/HIF-1α/VEGF Pathway. International Journal of Nanomedicine. 2026. doi:10.2147/ijn.s556912
BibTeX
@article{Wei2026,
author = {Wei, Aiqiu and Zhong, Ziyi and Zhang, Yiming and He, Jincheng and Pang, Haihe and Xia, Xinhua and Zhang, Xiaoqing},
title = {Aptamer-Mediated Dual-Loaded Liposomal Nanosystem for Synergistic Therapy in Hepatocellular Carcinoma via mTOR/HIF-1α/VEGF Pathway},
journal = {International Journal of Nanomedicine},
year = {2026},
doi = {10.2147/ijn.s556912}
}
EUVIMED